Home> Products> affordable antidiabetic medicines steris healthcare

{ "products": [ { "_id": "665da07fccd5ce1a1075551d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYDROZOLIN ISDN ", "description": "HYDROZOLIN ISDN \nIsosorbide Dinitrate (20mg), Hydralazine (37.5mg)\nHYDROZOLIN ISDN is a combination medication containing Isosorbide Dinitrate (20mg) and Hydralazine (37.5mg), used for the treatment of certain heart conditions.\n\nComponents:\n\nIsosorbide Dinitrate (ISDN): A vasodilator that relaxes and widens blood vessels, improving blood flow and reducing the workload on the heart.\nHydralazine: Another vasodilator that works by relaxing blood vessels, leading to decreased blood pressure and improved blood flow.\nUses:\n\nManagement of heart failure, a condition where the heart is unable to pump blood effectively.\nTreatment of hypertension (high blood pressure) in certain individuals.\nDosage:\nThe recommended dose of HYDROZOLIN ISDN may vary depending on the individual's condition and response to treatment. It's important to follow the dosage instructions provided by a healthcare professional.\n\nSide Effects:\nCommon side effects of HYDROZOLIN ISDN may include headache, dizziness, flushing, rapid heartbeat, and nausea. Serious side effects such as allergic reactions or low blood pressure may occur in some individuals. Consult a healthcare provider for a complete list of side effects.\n\nPrecautions:\n\nInform your healthcare provider about any medical conditions, medications, or supplements you are taking before starting HYDROZOLIN ISDN.\nMonitor blood pressure regularly while taking this medication.\nAvoid sudden discontinuation of HYDROZOLIN ISDN without medical supervision.\nConclusion:\nHYDROZOLIN ISDN, combining Isosorbide Dinitrate and Hydralazine, is used for the management of heart failure and hypertension. It should be used as directed by a healthcare professional, with regular monitoring for side effects and therapeutic response.\nSteris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/hydrozolin-isdn-133305\n\n", "price": 139.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GMP", "Call", "Uses", "Email", "group", "India", "Asthma", "nausea", "safety", "Urology", "company", "mission", "workload", "Oncology", "February", "flushing", "headache", "Diabetes", "WhatsApp", "customers", "medicines", "dizziness", "Nephrology", "Cardiology", "Components", "wide array", "commitment", "Pediatrics", "Management", "Conclusion", "blood flow", "Gynecology", "Dermatology", "information", "Hydralazine", "vasodilator", "supplements", "Dental Care", "medications", "Antibiotics", "Orthopedics", "Precautions", "convenience", "Navi Mumbai", "individuals", "hypertension", "two websites", "sterisonline", "diverse needs", "heart failure", "broad demands", "home delivery", "complete list", "Endocrinology", "blood vessels", "certifications", "WHO guidelines", "HYDROZOLIN ISDN", "rare conditions", "online pharmacy", "rapid heartbeat", "hydrozolin-isdn", "Gastroenterology", "General Medicine", "heart conditions", "Nasal Conditions", "recommended dose", "medical community", "affordable prices", "medical conditions", "low blood pressure", "Respiratory Issues", "high-quality drugs", "regular monitoring", "allergic reactions", "Common side effects", "high blood pressure", "healthcare provider", "healthcare products", "healthcare industry", "advanced treatments", "medical supervision", "dosage instructions", "sterispharma Order", "Isosorbide Dinitrate", "expert professionals", "Serious side effects", "therapeutic response", "various health areas", "sudden discontinuation", "combination medication", "pharmaceutical industry", "healthcare professional", "extensive product lineup", "Steris Healthcare Pvt Ltd", "essential health necessities" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1232, "imageuri": "https://productimages.withfloats.com/actual/665da0a0947ffd864eba7c72.png", "tileimageuri": "https://productimages.withfloats.com/tile/665da0a0947ffd864eba7c72.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T10:52:47.172Z", "updatedon": "2024-06-03T10:52:47.172Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/hydrozolin-isdn-/1232", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Isosorbide Dinitrate (20mg), Hydralazine (37.5mg)", "category": "CARDIOLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d24ff75f1701d34699e32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 80 ", "description": "GLICLAGLAZE 80 \nGliclazide (80mg)\nOverview\nGLICLAGLAZE 80 is an oral medication containing Gliclazide at a dosage of 80 mg. Gliclazide belongs to the class of drugs known as sulfonylureas and is primarily used to manage type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from the pancreatic beta cells. GLICLAGLAZE 80 is an effective treatment option for individuals who require oral hypoglycemic therapy to maintain optimal blood glucose levels.\n\nBenefits of Gliclazide\n\nBlood Sugar Control\n\nGliclazide effectively lowers blood glucose levels by increasing insulin secretion.\nHelps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.\nReduced Risk of Hypoglycemia\n\nCompared to some other sulfonylureas, Gliclazide has a lower risk of causing hypoglycemia (low blood sugar levels).\nIt provides a balanced approach to managing blood sugar without causing excessive drops in glucose levels.\nCardiovascular Benefits\n\nStudies suggest that Gliclazide may have a protective effect on the cardiovascular system.\nIt may reduce the risk of cardiovascular events in diabetic patients, promoting overall heart health.\nImproved Glycemic Control\n\nHelps achieve and maintain target HbA1c levels, reflecting long-term glycemic control.\nCan be used in combination with other oral antidiabetic agents or insulin to enhance its effectiveness.\nUsage and Dosage\nGLICLAGLAZE 80 should be taken as prescribed by a healthcare professional. The typical starting dose is 40 to 80 mg daily, which can be adjusted based on the patient's blood glucose response. It is usually taken with meals to maximize its effectiveness and minimize gastrointestinal side effects. Consistent use and adherence to prescribed dosage are crucial for optimal results.\n\nIndications for Use\n\nType 2 Diabetes Mellitus: GLICLAGLAZE 80 is indicated for the management of type 2 diabetes in patients who cannot achieve adequate glycemic control through diet and exercise alone.\nCombination Therapy: It can be used in conjunction with other oral hypoglycemic agents or insulin to achieve better blood sugar control.\nSide Effects\nGLICLAGLAZE 80 is generally well-tolerated. However, some patients may experience side effects, including:\n\nHypoglycemia: Although less common, low blood sugar can occur, especially if meals are skipped or combined with excessive physical activity.\nGastrointestinal Issues: Nausea, abdominal pain, and diarrhea may occur but are usually mild and transient.\nAllergic Reactions: Rarely, allergic reactions such as skin rash, itching, or hives may occur.\nPrecautions and Contraindications\n\nLiver and Kidney Impairment: Patients with severe liver or kidney disease should use GLICLAGLAZE 80 with caution, as it may require dose adjustments.\nPregnancy and Lactation: Gliclazide is not recommended during pregnancy or breastfeeding. Alternative treatments should be considered.\nDrug Interactions: Inform your healthcare provider about all medications and supplements you are taking, as Gliclazide can interact with other drugs, potentially altering its effectiveness.\nConclusion\nGLICLAGLAZE 80 is a reliable and effective oral medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood sugar levels, reducing the risk of diabetes-related complications. Its balanced approach to glycemic control, combined with potential cardiovascular benefits, makes GLICLAGLAZE 80 a valuable addition to diabetes management plans. Under the guidance of a healthcare professional, GLICLAGLAZE 80 can significantly improve the quality of life for individuals with type 2 diabetes, promoting better long-term health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 265.0, "discountamount": 79.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "skin rash", "lower risk", "40 to 80 mg", "other drugs", "severe liver", "Reduced Risk", "Consistent use", "kidney disease", "abdominal pain", "excessive drops", "optimal results", "dose adjustments", "diabetic patients", "insulin secretion", "valuable addition", "Drug Interactions", "Kidney Impairment", "protective effect", "balanced approach", "Allergic Reactions", "healthcare provider", "Combination Therapy", "other sulfonylureas", "Blood Sugar Control", "target HbA1c levels", "overall heart health", "cardiovascular events", "cardiovascular system", "typical starting dose", "pancreatic beta cells", "Alternative treatments", "blood glucose response", "low blood sugar levels", "healthcare professional", "Gastrointestinal Issues", "type 2 diabetes mellitus", "diabetes management plans", "adequate glycemic control", "effective oral medication", "long-term health outcomes", "oral hypoglycemic therapy", "long-term glycemic control", "effective treatment option", "excessive physical activity", "optimal blood glucose levels", "gastrointestinal side effects", "diabetes-related complications", "other oral hypoglycemic agents", "other oral antidiabetic agents", "potential cardiovascular benefits" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1922, "imageuri": "https://productimages.withfloats.com/actual/668d2505c34ba6457aa3fb4d.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668d2505c34ba6457aa3fb4d.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:54:39.186Z", "updatedon": "2024-07-09T11:54:39.186Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-80-/1922", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE 80 ", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 80mg side effects", "Gliclazide 80mg dosage", "Gliclazide 80mg Metformin 500mg", "Gliclazide 80mg price", "Gliclazide 80mg uses", "Gliclazide 80mg Uses in Hindi", "Gliclazide 80mg before or after meal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 4 ", "description": "NICOMALOM 4 \nNicoumalone (4mg)\nIntroduction:\n\nNICOMALOM 4 contains Nicoumalone (4 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 4 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 4 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-4-133593", "price": 389.4, "discountamount": 116.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2024-06-27T08:29:00.414Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-4-/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "acitrom 4mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abf93396cee0250f91bbf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 3 ", "description": "NICOMALOM 3 \nNicoumalone (3mg)\nIntroduction:\n\nNICOMALOM 3 contains Nicoumalone (3 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 3 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 3 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-3-133592", "price": 359.4, "discountamount": 107.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "EMAIL", "water", "Doses", "heart", "tablet", "product", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "3 mg dosage", "information", "INR) levels", "Nicoumalone", "initial dose", "sterisonline", "Key Features", "sterispharma", "Introduction", "CALL/WHATSAPP", "long-term use", "Initial Dosage", "Administration", "prothrombin time", "most indications", "target INR range", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1861, "imageuri": "https://productimages.withfloats.com/actual/666abf968b71a2cb2d7d4e2d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abf968b71a2cb2d7d4e2d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:44:51.78Z", "updatedon": "2024-06-26T11:15:50.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-3-/1861", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 3 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 3mg uses", "nicoumalone side effects", "nicoumalone tablet uses in hindi", "nicoumalone contraindications", "nicoumalone tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 2 ", "description": "NICOMALOM 2 \nNicoumalone (2mg)\nIntroduction:\n\nNICOMALOM 2 contains Nicoumalone (2 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 2 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 2 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/nicomalom-2-133591", "price": 243.0, "discountamount": 72.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2024-06-26T11:13:41.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicomalom-2-/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abcb0f7438b1754ba0c31", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 1 ", "description": "NICOMALOM 1 \nNicoumalone (1mg)\nIntroduction:\n\nNICOMALOM 1 contains Nicoumalone (1 mg), an anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 1 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 1 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-1-133590", "price": 183.0, "discountamount": 54.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "Doses", "heart", "EMAIL", "water", "tablet", "product", "Benefits", "patients", "NICOMALOM", "same time", "synthesis", "Nicoumalone", "INR) levels", "1 mg dosage", "information", "Introduction", "initial dose", "sterispharma", "Key Features", "sterisonline", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "most indications", "target INR range", "prothrombin time", "maintenance dose", "affordable option", "Maintenance Dosage", "careful monitoring", "chronic conditions", "pulmonary embolism", "healthcare provider", "atrial fibrillation", "regular blood tests", "Standardized Dosing", "precise adjustments", "Long-Term Management", "deep vein thrombosis", "blood clot formation", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "optimal anticoagulation", "consistent blood levels", "thromboembolic disorders", "anticoagulant medication", "Thromboembolism Prevention", "International Normalized Ratio", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1859, "imageuri": "https://productimages.withfloats.com/actual/666abcb4f068be46bdeaf907.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abcb4f068be46bdeaf907.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:32:32.095Z", "updatedon": "2024-06-26T11:06:41.45Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-1-/1859", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 1 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone tablet 1mg", "nicoumalone 1mg uses in hindi", "nicoumalone 1mg price", "", "nicoumalone class of drug", "acenocoumarol drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66696590cee93a1bbc381d05", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BISALATIN 40", "description": "BISALATIN 40\nBilastine (40mg)\nBisalatin M is a combination medication containing two active ingredients: Bilastine and Montelukast. Bilastine is an antihistamine used to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria. Montelukast is a leukotriene receptor antagonist that helps in managing asthma and allergic rhinitis symptoms.\n\nUses:\n\nBilastine: Treats allergic rhinitis and chronic idiopathic urticaria.\nMontelukast: Manages symptoms of asthma and allergic rhinitis.\nDosage:\nThe dosage of Bisalatin M varies based on the patient's age, medical condition, and response to treatment. It is typically taken once daily as prescribed by a healthcare professional.\n\nSide Effects:\nCommon side effects may include headache, drowsiness, dry mouth, nausea, and fatigue. Serious side effects are rare but may include allergic reactions, mood changes, or liver problems. Consult a doctor if any adverse effects occur.\n\nPrice:\nThe price of Bisalatin M can vary depending on the dosage strength, quantity, and pharmacy location. It is available in both generic and brand-name forms, with generic options usually being more affordable.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/bisalatin-40-133724", "price": 199.0, "discountamount": 60.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Uses", "Call", "ORDER", "Email", "Price", "nausea", "doctor", "asthma", "fatigue", "patient", "headache", "response", "WhatsApp", "quantity", "dry mouth", "treatment", "Bilastine", "drowsiness", "information", "Bisalatin M", "Montelukast", "sterispharma", "sterisonline", "mood changes", "antihistamine", "liver problems", "dosage strength", "generic options", "adverse effects", "brand-name forms", "pharmacy location", "medical condition", "allergic reactions", "Common side effects", "Serious side effects", "combination medication", "two active ingredients", "healthcare professional", "allergic rhinitis symptoms", "chronic idiopathic urticaria", "leukotriene receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1798, "imageuri": "https://productimages.withfloats.com/actual/666965938c6c791fd3b30105.png", "tileimageuri": "https://productimages.withfloats.com/tile/666965938c6c791fd3b30105.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T09:08:32.937Z", "updatedon": "2024-06-27T06:38:53.482Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bisalatin-40/1798", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BISALATIN 40", "category": "RESPIRTORYRANGE", "tags": [ "BISALATIN 40 mg", "Bilastine 40mg uses", "Bilastine 40mg dosage", "BISALATIN 40", "Bilastine 40mg side effects", "BISALATIN 40", "Bilastine 40mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }